Close
Nordic 9Nordic 9

Ginkgo Bioworks (investor - Corporate Investor)

United States
See something wrong or missing? Let us know
Offices:Boston

Ginkgo Bioworks is an American biotech company founded by Tom Knight in Boston.

Average round investment:N/A USD
Average number per year:0.0
Distribution: 2025 (1)
Portfolio companies: Denmark Octarine Bio
Mostly invests in: Denmark Denmark (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ginkgo Bioworks

Name Criteria
Sweden Litorina
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Fashion, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Active last 12 months: Yes
Italy Golgi NueroSciences
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Active last 12 months: Yes
Denmark Bagger-Sørensen Equity A/S
79%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Active last 12 months: Yes
Denmark Dansk Ejerkapital
78%
  • Range for average deal size: n/a USD
  • Similar verticals: Fashion, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Active last 12 months: Yes
Switzerland SNGLR Capital
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Austria Biogena Group Invest Ag
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Germany Ortho Innovations
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Triathlon Group
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Ekeblad Bostad
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Belgium Annemie Van de Casteele
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Active last 12 months: Yes
Top